Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novonix (NVX) Cash & Equivalents (2020 - 2025)

Novonix (NVX) has 6 years of Cash & Equivalents data on record, last reported at $79.9 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 87.56% year-over-year to $79.9 million; the TTM value through Dec 2025 reached $79.9 million, up 87.56%, while the annual FY2025 figure was $79.9 million, 87.56% up from the prior year.
  • Cash & Equivalents reached $79.9 million in Q4 2025 per NVX's latest filing, up from $42.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $148.3 million in Q2 2022 and bottomed at $42.6 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $92.3 million, with a median of $89.5 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: surged 294.3% in 2021, then plummeted 45.88% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $105.2 million in 2021, then fell by 5.89% to $99.0 million in 2022, then decreased by 20.52% to $78.7 million in 2023, then tumbled by 45.88% to $42.6 million in 2024, then skyrocketed by 87.56% to $79.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $79.9 million in Q4 2025, $42.6 million in Q4 2024, and $78.7 million in Q4 2023.